D-0468-2017 Class III Terminated
FDA drug recall D-0468-2017 was initiated by Dr. Reddy's Laboratories, Inc. on Oct 13, 2016 and is designated Class III. Reason for recall: Failed impurities/degradation specifications: due to out-of-specification result for the Related Substance Compound C (Impurity 6 - N-Oxide at the 18 month stability station. The recall status is terminated (terminated Jul 24, 2017). Affected quantity: 5,904 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 15, 2017
- Initiation Date
- Oct 13, 2016
- Termination Date
- Jul 24, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 5,904 bottles
Product description
Olanzapine tablets, USP, 2.5 mg, packaged in a 30-count bottle, Rx only, Mfd: By: Dr. Reddy's Laboratories Limited, Bachupally, India, NDC 55111-163-30
Reason for recall
Failed impurities/degradation specifications: due to out-of-specification result for the Related Substance Compound C (Impurity 6 - N-Oxide at the 18 month stability station.
Distribution pattern
US Nationwide
Code information
C500202
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0468-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026